Document Detail

Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed.
MedLine Citation:
PMID:  16159078     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Women on hormonal therapy for menorrhagia are at risk for cerebral venous thrombosis. CASE REPORT: This scenario may become complicated when there is profuse vaginal bleed with the withdrawal of hormonal therapy. There are no reports describing the possible therapeutic approaches in this clinical situation. RESULTS: A 42-year-old female with a history of uterine fibroids and menorrhagia taking an estrogen-progesterone combination pill presented with seizure clusters. Neuro-imaging showed lateral sinus thrombosis and biparietal hemorrhagic infarcts. Withdrawal of the contraceptive pill was associated with profuse vaginal bleed, leading to hemodynamic instability and the need for multiple blood transfusions. As an emergent procedure to stop the vaginal bleeding, the patient was implanted with a levonorgestrel intrauterine system; with this, vaginal bleed stopped within 12 hours with hemodynamic stability. Subsequently, the patient was treated with unfractionated heparin followed by warfarin (target international normalized ratio: 2.5-3). She made a good neurological recovery. CONCLUSION: This case illustrates that LNG-IUS can be an innovative choice for local hormonal therapy in a patient with OCP-related cerebral venous thrombosis and simultaneous vaginal bleeding.
T Jayashree Narayanan; G V S Chowdary; J M K Murthy
Related Documents :
20103278 - Managing fibrinolysis without aprotinin.
25221718 - Prosthetic rehabilitation of patients with maxillary defects in a nigerian tertiary hos...
12709698 - Predictors of bleeding after endoscopic mucosal resection of gastric tumors.
20703888 - Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.
7224748 - Maternal meconium granulomatous peritonitis.
15516448 - Delayed hemorrhage after cervical conization unmasking severe factor xi deficiency.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Neurocritical care     Volume:  2     ISSN:  1541-6933     ISO Abbreviation:  Neurocrit Care     Publication Date:  2005  
Date Detail:
Created Date:  2005-09-14     Completed Date:  2005-11-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101156086     Medline TA:  Neurocrit Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  292-5     Citation Subset:  IM    
Department of Neurology, The Institute of Neurological Sciences, CARE Hospital, Nampally, Hydarabad 500 001, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Contraceptives, Oral, Combined / adverse effects*
Ethinyl Estradiol-Norgestrel Combination / adverse effects*
Intrauterine Devices, Medicated
Lateral Sinus Thrombosis / chemically induced*,  diagnosis,  therapy
Levonorgestrel / administration & dosage
Menorrhagia / drug therapy*
Reg. No./Substance:
0/Contraceptives, Oral, Combined; 797-63-7/Levonorgestrel; 8056-51-7/Ethinyl Estradiol-Norgestrel Combination

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Paroxysmal sympathetic storm.
Next Document:  Reversal of locked-in syndrome with anticoagulation, induced hypertension, and intravenous t-PA.